Previous studies have confirmed that FOXO3a functions as a tumor suppressor gene in breast cancer, inhibiting VEGF-A/NRP1 signaling and breast cancer metastasis by driving miRNA signatures [45]. This evidence concerns the gene NRP1 and breast carcinoma.